 | • レポートコード：GIR-107A14762 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、T細胞表面糖タンパク質CD4のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。T細胞表面糖タンパク質CD4の種類別市場規模（酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他）、用途別市場規模（HIV、エイズ、GVHD、SARS、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・T細胞表面糖タンパク質CD4の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Biotest AG、Bristol-Myers Squibb Co、CEL-SCI Corp、Fountain Biopharma Inc、Immupharma Plc、Sanofi、TaiMed Biologics Inc、United Biomedical Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：酢酸フォリゲリモド、HIVワクチン2、イバリズマブ、その他 ・用途別分析2016年-2026年：HIV、エイズ、GVHD、SARS、その他 ・T細胞表面糖タンパク質CD4の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・T細胞表面糖タンパク質CD4のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・T細胞表面糖タンパク質CD4のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・T細胞表面糖タンパク質CD4の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・T細胞表面糖タンパク質CD4の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The T Cell Surface Glycoprotein CD4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global T Cell Surface Glycoprotein CD4 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global T Cell Surface Glycoprotein CD4 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
T Cell Surface Glycoprotein CD4 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Forigerimod Acetate
HIV Vaccine 2
Ibalizumab
Others
Market segment by Application can be divided into
HIV
AIDS
GVHD
SARS
Others
The key market players for global T Cell Surface Glycoprotein CD4 market are listed below:
Biotest AG
Bristol-Myers Squibb Co
CEL-SCI Corp
Fountain Biopharma Inc
Immupharma Plc
Sanofi
TaiMed Biologics Inc
United Biomedical Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe T Cell Surface Glycoprotein CD4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of T Cell Surface Glycoprotein CD4, with price, sales, revenue and global market share of T Cell Surface Glycoprotein CD4 from 2019 to 2021.
Chapter 3, the T Cell Surface Glycoprotein CD4 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the T Cell Surface Glycoprotein CD4 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and T Cell Surface Glycoprotein CD4 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe T Cell Surface Glycoprotein CD4 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 T Cell Surface Glycoprotein CD4 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global T Cell Surface Glycoprotein CD4 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Forigerimod Acetate
1.2.3 HIV Vaccine 2
1.2.4 Ibalizumab
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global T Cell Surface Glycoprotein CD4 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 HIV
1.3.3 AIDS
1.3.4 GVHD
1.3.5 SARS
1.3.6 Others
1.4 Global T Cell Surface Glycoprotein CD4 Market Size & Forecast
1.4.1 Global T Cell Surface Glycoprotein CD4 Sales in Value (2016-2026))
1.4.2 Global T Cell Surface Glycoprotein CD4 Sales in Volume (2016-2026)
1.4.3 Global T Cell Surface Glycoprotein CD4 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global T Cell Surface Glycoprotein CD4 Production Capacity Analysis
1.5.1 Global T Cell Surface Glycoprotein CD4 Total Production Capacity (2016-2026)
1.5.2 Global T Cell Surface Glycoprotein CD4 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 T Cell Surface Glycoprotein CD4 Market Drivers
1.6.2 T Cell Surface Glycoprotein CD4 Market Restraints
1.6.3 T Cell Surface Glycoprotein CD4 Trends Analysis
2 Manufacturers Profiles
2.1 Biotest AG
2.1.1 Biotest AG Details
2.1.2 Biotest AG Major Business
2.1.3 Biotest AG T Cell Surface Glycoprotein CD4 Product and Services
2.1.4 Biotest AG T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bristol-Myers Squibb Co
2.2.1 Bristol-Myers Squibb Co Details
2.2.2 Bristol-Myers Squibb Co Major Business
2.2.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product and Services
2.2.4 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 CEL-SCI Corp
2.3.1 CEL-SCI Corp Details
2.3.2 CEL-SCI Corp Major Business
2.3.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product and Services
2.3.4 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Fountain Biopharma Inc
2.4.1 Fountain Biopharma Inc Details
2.4.2 Fountain Biopharma Inc Major Business
2.4.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product and Services
2.4.4 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Immupharma Plc
2.5.1 Immupharma Plc Details
2.5.2 Immupharma Plc Major Business
2.5.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Product and Services
2.5.4 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi T Cell Surface Glycoprotein CD4 Product and Services
2.6.4 Sanofi T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 TaiMed Biologics Inc
2.7.1 TaiMed Biologics Inc Details
2.7.2 TaiMed Biologics Inc Major Business
2.7.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product and Services
2.7.4 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 United Biomedical Inc
2.8.1 United Biomedical Inc Details
2.8.2 United Biomedical Inc Major Business
2.8.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Product and Services
2.8.4 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 T Cell Surface Glycoprotein CD4 Sales by Manufacturer
3.1 Global T Cell Surface Glycoprotein CD4 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global T Cell Surface Glycoprotein CD4 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in T Cell Surface Glycoprotein CD4
3.4 Market Concentration Rate
3.4.1 Top 3 T Cell Surface Glycoprotein CD4 Manufacturer Market Share
3.4.2 Top 6 T Cell Surface Glycoprotein CD4 Manufacturer Market Share
3.5 Global T Cell Surface Glycoprotein CD4 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and T Cell Surface Glycoprotein CD4 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global T Cell Surface Glycoprotein CD4 Market Size by Region
4.1.1 Global T Cell Surface Glycoprotein CD4 Sales in Volume by Region (2016-2026)
4.1.2 Global T Cell Surface Glycoprotein CD4 Revenue by Region (2016-2026)
4.2 North America T Cell Surface Glycoprotein CD4 Revenue (2016-2026)
4.3 Europe T Cell Surface Glycoprotein CD4 Revenue (2016-2026)
4.4 Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue (2016-2026)
4.5 South America T Cell Surface Glycoprotein CD4 Revenue (2016-2026)
4.6 Middle East and Africa T Cell Surface Glycoprotein CD4 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global T Cell Surface Glycoprotein CD4 Sales in Volume by Type (2016-2026)
5.2 Global T Cell Surface Glycoprotein CD4 Revenue by Type (2016-2026)
5.3 Global T Cell Surface Glycoprotein CD4 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global T Cell Surface Glycoprotein CD4 Sales in Volume by Application (2016-2026)
6.2 Global T Cell Surface Glycoprotein CD4 Revenue by Application (2016-2026)
6.3 Global T Cell Surface Glycoprotein CD4 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America T Cell Surface Glycoprotein CD4 Sales by Type (2016-2026)
7.2 North America T Cell Surface Glycoprotein CD4 Sales by Application (2016-2026)
7.3 North America T Cell Surface Glycoprotein CD4 Market Size by Country
7.3.1 North America T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2016-2026)
7.3.2 North America T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe T Cell Surface Glycoprotein CD4 Sales by Type (2016-2026)
8.2 Europe T Cell Surface Glycoprotein CD4 Sales by Application (2016-2026)
8.3 Europe T Cell Surface Glycoprotein CD4 Market Size by Country
8.3.1 Europe T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2016-2026)
8.3.2 Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Type (2016-2026)
9.2 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Application (2016-2026)
9.3 Asia-Pacific T Cell Surface Glycoprotein CD4 Market Size by Region
9.3.1 Asia-Pacific T Cell Surface Glycoprotein CD4 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America T Cell Surface Glycoprotein CD4 Sales by Type (2016-2026)
10.2 South America T Cell Surface Glycoprotein CD4 Sales by Application (2016-2026)
10.3 South America T Cell Surface Glycoprotein CD4 Market Size by Country
10.3.1 South America T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2016-2026)
10.3.2 South America T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Type (2016-2026)
11.2 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Application (2016-2026)
11.3 Middle East & Africa T Cell Surface Glycoprotein CD4 Market Size by Country
11.3.1 Middle East & Africa T Cell Surface Glycoprotein CD4 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 T Cell Surface Glycoprotein CD4 Typical Distributors
12.3 T Cell Surface Glycoprotein CD4 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global T Cell Surface Glycoprotein CD4 Revenue by Type, (USD Million), 2021-2026
Table 2. Global T Cell Surface Glycoprotein CD4 Revenue by Application, (USD Million), 2021-2026
Table 3. Biotest AG Basic Information, Manufacturing Base and Competitors
Table 4. Biotest AG Major Business
Table 5. Biotest AG T Cell Surface Glycoprotein CD4 Product and Services
Table 6. Biotest AG T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Co Major Business
Table 9. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product and Services
Table 10. Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. CEL-SCI Corp Basic Information, Manufacturing Base and Competitors
Table 12. CEL-SCI Corp Major Business
Table 13. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product and Services
Table 14. CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Fountain Biopharma Inc Basic Information, Manufacturing Base and Competitors
Table 16. Fountain Biopharma Inc Major Business
Table 17. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product and Services
Table 18. Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Immupharma Plc Basic Information, Manufacturing Base and Competitors
Table 20. Immupharma Plc Major Business
Table 21. Immupharma Plc T Cell Surface Glycoprotein CD4 Product and Services
Table 22. Immupharma Plc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi T Cell Surface Glycoprotein CD4 Product and Services
Table 26. Sanofi T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. TaiMed Biologics Inc Basic Information, Manufacturing Base and Competitors
Table 28. TaiMed Biologics Inc Major Business
Table 29. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product and Services
Table 30. TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. United Biomedical Inc Basic Information, Manufacturing Base and Competitors
Table 32. United Biomedical Inc Major Business
Table 33. United Biomedical Inc T Cell Surface Glycoprotein CD4 Product and Services
Table 34. United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global T Cell Surface Glycoprotein CD4 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 36. Global T Cell Surface Glycoprotein CD4 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in T Cell Surface Glycoprotein CD4, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global T Cell Surface Glycoprotein CD4 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 39. Head Office and T Cell Surface Glycoprotein CD4 Production Site of Key Manufacturer
Table 40. T Cell Surface Glycoprotein CD4 New Entrant and Capacity Expansion Plans
Table 41. T Cell Surface Glycoprotein CD4 Mergers & Acquisitions in the Past Five Years
Table 42. Global T Cell Surface Glycoprotein CD4 Sales by Region (2016-2021e) & (K Pcs)
Table 43. Global T Cell Surface Glycoprotein CD4 Sales by Region (2021-2026) & (K Pcs)
Table 44. Global T Cell Surface Glycoprotein CD4 Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global T Cell Surface Glycoprotein CD4 Revenue by Region (2021-2026) & (USD Million)
Table 46. Global T Cell Surface Glycoprotein CD4 Sales by Type (2016-2021e) & (K Pcs)
Table 47. Global T Cell Surface Glycoprotein CD4 Sales by Type (2021-2026) & (K Pcs)
Table 48. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global T Cell Surface Glycoprotein CD4 Revenue by Type (2021-2026) & (USD Million)
Table 50. Global T Cell Surface Glycoprotein CD4 Price by Type (2016-2021e) & (USD/Pcs)
Table 51. Global T Cell Surface Glycoprotein CD4 Price by Type (2021-2026) & (USD/Pcs)
Table 52. Global T Cell Surface Glycoprotein CD4 Sales by Application (2016-2021e) & (K Pcs)
Table 53. Global T Cell Surface Glycoprotein CD4 Sales by Application (2021-2026) & (K Pcs)
Table 54. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global T Cell Surface Glycoprotein CD4 Revenue by Application (2021-2026) & (USD Million)
Table 56. Global T Cell Surface Glycoprotein CD4 Price by Application (2016-2021e) & (USD/Pcs)
Table 57. Global T Cell Surface Glycoprotein CD4 Price by Application (2021-2026) & (USD/Pcs)
Table 58. North America T Cell Surface Glycoprotein CD4 Sales by Country (2016-2021e) & (K Pcs)
Table 59. North America T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Pcs)
Table 60. North America T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America T Cell Surface Glycoprotein CD4 Revenue by Country (2021-2026) & (USD Million)
Table 62. North America T Cell Surface Glycoprotein CD4 Sales by Type (2016-2021e) & (K Pcs)
Table 63. North America T Cell Surface Glycoprotein CD4 Sales by Type (2021-2026) & (K Pcs)
Table 64. North America T Cell Surface Glycoprotein CD4 Sales by Application (2016-2021e) & (K Pcs)
Table 65. North America T Cell Surface Glycoprotein CD4 Sales by Application (2021-2026) & (K Pcs)
Table 66. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2016-2021e) & (K Pcs)
Table 67. Europe T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Pcs)
Table 68. Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe T Cell Surface Glycoprotein CD4 Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe T Cell Surface Glycoprotein CD4 Sales by Type (2016-2021e) & (K Pcs)
Table 71. Europe T Cell Surface Glycoprotein CD4 Sales by Type (2021-2026) & (K Pcs)
Table 72. Europe T Cell Surface Glycoprotein CD4 Sales by Application (2016-2021e) & (K Pcs)
Table 73. Europe T Cell Surface Glycoprotein CD4 Sales by Application (2021-2026) & (K Pcs)
Table 74. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Region (2016-2021e) & (K Pcs)
Table 75. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Region (2021-2026) & (K Pcs)
Table 76. Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Type (2016-2021e) & (K Pcs)
Table 79. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Type (2021-2026) & (K Pcs)
Table 80. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Application (2016-2021e) & (K Pcs)
Table 81. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales by Application (2021-2026) & (K Pcs)
Table 82. South America T Cell Surface Glycoprotein CD4 Sales by Country (2016-2021e) & (K Pcs)
Table 83. South America T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Pcs)
Table 84. South America T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America T Cell Surface Glycoprotein CD4 Revenue by Country (2021-2026) & (USD Million)
Table 86. South America T Cell Surface Glycoprotein CD4 Sales by Type (2016-2021e) & (K Pcs)
Table 87. South America T Cell Surface Glycoprotein CD4 Sales by Type (2021-2026) & (K Pcs)
Table 88. South America T Cell Surface Glycoprotein CD4 Sales by Application (2016-2021e) & (K Pcs)
Table 89. South America T Cell Surface Glycoprotein CD4 Sales by Application (2021-2026) & (K Pcs)
Table 90. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Country (2016-2021e) & (K Pcs)
Table 91. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Country (2021-2026) & (K Pcs)
Table 92. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Type (2016-2021e) & (K Pcs)
Table 95. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Type (2021-2026) & (K Pcs)
Table 96. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Application (2016-2021e) & (K Pcs)
Table 97. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales by Application (2021-2026) & (K Pcs)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. T Cell Surface Glycoprotein CD4 Typical Distributors
Table 101. T Cell Surface Glycoprotein CD4 Typical Customers
List of Figures
Figure 1. T Cell Surface Glycoprotein CD4 Picture
Figure 2. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type in 2020
Figure 3. Forigerimod Acetate
Figure 4. HIV Vaccine 2
Figure 5. Ibalizumab
Figure 6. Others
Figure 7. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application in 2020
Figure 8. HIV
Figure 9. AIDS
Figure 10. GVHD
Figure 11. SARS
Figure 12. Others
Figure 13. Global T Cell Surface Glycoprotein CD4 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global T Cell Surface Glycoprotein CD4 Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global T Cell Surface Glycoprotein CD4 Sales (2016-2026) & (K Pcs)
Figure 16. Global T Cell Surface Glycoprotein CD4 Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global T Cell Surface Glycoprotein CD4 Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global T Cell Surface Glycoprotein CD4 Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. T Cell Surface Glycoprotein CD4 Market Drivers
Figure 20. T Cell Surface Glycoprotein CD4 Market Restraints
Figure 21. T Cell Surface Glycoprotein CD4 Market Trends
Figure 22. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Manufacturer in 2020
Figure 23. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Manufacturer in 2020
Figure 24. T Cell Surface Glycoprotein CD4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 T Cell Surface Glycoprotein CD4 Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 T Cell Surface Glycoprotein CD4 Manufacturer (Revenue) Market Share in 2020
Figure 27. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2016-2026)
Figure 28. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2016-2026)
Figure 29. North America T Cell Surface Glycoprotein CD4 Revenue (2016-2026) & (USD Million)
Figure 30. Europe T Cell Surface Glycoprotein CD4 Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue (2016-2026) & (USD Million)
Figure 32. South America T Cell Surface Glycoprotein CD4 Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue (2016-2026) & (USD Million)
Figure 34. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2016-2026)
Figure 35. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Type (2016-2026)
Figure 36. Global T Cell Surface Glycoprotein CD4 Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2016-2026)
Figure 38. Global T Cell Surface Glycoprotein CD4 Revenue Market Share by Application (2016-2026)
Figure 39. Global T Cell Surface Glycoprotein CD4 Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2016-2026)
Figure 41. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2016-2026)
Figure 42. North America T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2016-2026)
Figure 43. North America T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2016-2026)
Figure 44. United States T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2016-2026)
Figure 48. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2016-2026)
Figure 49. Europe T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2016-2026)
Figure 50. Europe T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2016-2026)
Figure 51. Germany T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific T Cell Surface Glycoprotein CD4 Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific T Cell Surface Glycoprotein CD4 Revenue Market Share by Region (2016-2026)
Figure 60. China T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2016-2026)
Figure 67. South America T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2016-2026)
Figure 68. South America T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2016-2026)
Figure 69. South America T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2016-2026)
Figure 70. Brazil T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa T Cell Surface Glycoprotein CD4 Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue Market Share by Country (2016-2026)
Figure 76. Turkey T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa T Cell Surface Glycoprotein CD4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の呼吸器合胞体ウイルス付着糖タンパク質市場 2021：企業別、地域別、種類・用途別 The Respiratory Syncytial Virus Attachment Glycoprotein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…- 世界の樹状細胞・腫瘍細胞がんワクチン市場 2021：企業別、地域別、種類・用途別 The Dendritic Cell and Tumor Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の全細胞コレラワクチン市場 2021：企業別、地域別、種類・用途別 The Whole Cell Cholera Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 世界の遺伝子組換え型チャイニーズハムスター卵巣（CHO）B型肝炎ワクチン市場 2021：企業別、地域別、種類・用途別 The Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 世界の糖衣錠キャンディー（サル肝細胞）におけるポリオワクチン市場 2021：企業別、地域別、種類・用途別 The Poliomycetes Vaccine in Dragee Candy (Monkey Liver Cell) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …